
Récepteur Trk
Les inhibiteurs des récepteurs Trk ciblent les kinases des récepteurs de la tropomyosine (Trk), une famille de récepteurs à activité tyrosine kinase qui jouent un rôle important dans le développement et la fonction du système nerveux. Les récepteurs Trk sont impliqués dans la signalisation des neurotrophines, essentielle à la survie, à la différenciation et à la croissance des neurones. La dérégulation de la signalisation Trk est associée à des troubles neurologiques et à certains cancers. Chez CymitQuimica, nous proposons des inhibiteurs de récepteurs Trk pour soutenir vos recherches en neurobiologie, oncologie et maladies neurodégénératives.
Produits appartenant à la catégorie "Récepteur Trk"
Trier par
TRK II-IN-1
CAS :TRK II-IN-1: potent type II TRK inhibitor; IC50s: TRKA (3.3 nM), TRKB (6.4 nM), TRKC (4.3 nM), TRKA G667C (9.4 nM); also targets FLT3, RET, VEGFR2.Formule :C29H31F3N8ODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :564.6BNN-20
CAS :BNN-20 is a synthetic micro-neurotrophic factor that mimics Brain-Derived Neurotrophic Factor (BDNF) and exhibits region-specific neuroprotective and neurogenesis-promoting effects. It is applicable in research related to Parkinson's disease.Formule :C20H30O2Couleur et forme :SolidMasse moléculaire :302.45Entrectinib
CAS :Entrectinib (RXDX-101) is an orally Trk, ROS1, and ALK inhibitor. Entrectinib exhibits antitumor activity. Cost-effective and quality-assured.Formule :C31H34F2N6O2Degré de pureté :98.03% - 99.61%Couleur et forme :SolidMasse moléculaire :560.64Ref: TM-T3678
2mg42,00€5mg59,00€10mg88,00€25mg111,00€50mg168,00€100mg283,00€500mg692,00€1mL*10mM (DMSO)69,00€Protein kinase inhibitor 5 sulfate hydrate
Protein kinase inhibitor 5 sulfate hydrate, a potent TRK-A inhibitor, exhibits an IC50 of 1.8 nM and impairs cell viability [1].Formule :C29H35F2N7O6SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :647.69Sitravatinib
CAS :Sitravatinib (MGCD516) (MGCD516) is an inhibitor targeting multiple RTKs involved in driving sarcoma cell growth, including c-Met, c-Kit, PDGFRα/β, PDGFR, andFormule :C33H29F2N5O4SDegré de pureté :98.9% - 99.74%Couleur et forme :SolidMasse moléculaire :629.68Ref: TM-T4349
5mg51,00€10mg79,00€25mg137,00€50mg210,00€100mg338,00€200mg535,00€500mg845,00€1mL*10mM (DMSO)72,00€GNF-5837
CAS :GNF-5837 is a specific, and orally bioavailable pan-TRK inhibitor for TrkA/TrkB (IC50: 8/12 nM).Formule :C28H21F4N5O2Degré de pureté :96.17% - 99.29%Couleur et forme :SolidMasse moléculaire :535.49Ref: TM-T6097
5mg50,00€10mg85,00€25mg124,00€50mg188,00€100mg311,00€200mg404,00€500mg657,00€1mL*10mM (DMSO)56,00€ALE-0540
CAS :ALE-0540: nonpeptidic heterocycle, blocks NGF binding to p75/TrkA and TrkA-mediated signaling.Formule :C14H11N3O5Degré de pureté :97.25%Couleur et forme :SolidMasse moléculaire :301.25Ref: TM-T9292
2mg35,00€5mg55,00€10mg88,00€25mg133,00€50mg188,00€100mg269,00€200mg369,00€1mL*10mM (DMSO)60,00€TrkB-IN-1
CAS :TrkB-IN-1 is a potent, orally active agonist of the TrkB receptor, with favorable pharmacokinetic (PK) properties.Formule :C19H16N2O6Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :368.34Type II TRK inhibitor 1
CAS :Type II TRK Inhibitor 1 is a potent inhibitor targeting multiple tropomyosin receptor kinase (TRK) fusion protein variants as well as the wild type.Formule :C35H33F3N8O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :670.68TrkA-IN-1
CAS :TrkA-IN-1 is a potent and selective inhibitor of Tropomyosin-related kinase A (TrkA) (IC50: 99 nM in a cell-based assay) with analgesic activity.Formule :C25H20N4ODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :392.45Protein kinase inhibitor 5
CAS :Protein kinase inhibitor 5 is a potent inhibitor of TRK-A, demonstrating an IC50 of 1.8 nM, and effectively suppresses cell viability [1].Formule :C29H31F2N7ODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :531.6CH7057288
CAS :CH7057288 is an effective and selective TRK inhibitor with an IC50 value of 1.1 nM, 7.8 nM and 5.1 nM for TRKA, TRKB and TRKC, respectively.Formule :C32H31N3O5SDegré de pureté :99.92%Couleur et forme :SolidMasse moléculaire :569.67Selitrectinib
CAS :Selitrectinib (LOXO-195) is a potent and selective inhibitor of the receptor tyrosine kinases(TRK).Cost-effective and quality-assured.Formule :C20H21FN6ODegré de pureté :99.55% - ≥95%Couleur et forme :SolidMasse moléculaire :380.42PF-06273340
CAS :PF-06273340 是一种口服具有活力的、具有选择性的外周限制性Trk 泛抑制剂。Formule :C23H22ClN7O3Degré de pureté :98% - 98.00%Couleur et forme :SolidMasse moléculaire :479.92ENT-C225
CAS :ENT-C225 is a potent TrkB neurotrophin receptor (TrkBR) activator with neuroprotective activity for the study of Alzheimer's disease and Parkinson's disease.Formule :C26H40N4O5Degré de pureté :99.16% - 99.16%Couleur et forme :SolidMasse moléculaire :488.62ONO-7475
CAS :ONO-7475 is an inhibitor with high specificity for anexelekto and MER tyrosine kinaseFormule :C32H26N4O6Degré de pureté :98.74%Couleur et forme :SolidMasse moléculaire :562.57ANA-12
CAS :ANA-12 is a potent and selective TrkB antagonist with anxiolytic and antidepressant activity in mice.Formule :C22H21N3O3SDegré de pureté :99.28% - 99.87%Couleur et forme :SolidMasse moléculaire :407.49NMS-P626
CAS :NMS-P626 functions as an inhibitor targeting TRKA, TRKB, and TRKC, exhibiting IC 50 values of 8 nM, 7 nM, and 3 nM respectively. It effectively suppresses KM12 cell growth by inhibiting the phosphorylation of TPM3-TRKA and the subsequent downstream signaling, demonstrating an IC 50 of 19 nM specifically for KM12 cells. This compound is applicable in the study of colorectal cancer.Formule :C28H35F2N7O4SCouleur et forme :SolidMasse moléculaire :603.68Larotrectinib
CAS :Larotrectinib (LOXO-101) is an orally administered inhibitor of the TRK kinase and is highly selective only for the TRK family of receptors(IC50s = 2-20 nM).Formule :C21H22F2N6O2Degré de pureté :100% - 99.15%Couleur et forme :SolidMasse moléculaire :428.44Ref: TM-T5995
1mg39,00€5mg79,00€10mg96,00€25mg165,00€50mg250,00€100mg376,00€500mg867,00€1mL*10mM (DMSO)86,00€LM22B-10
CAS :LM22B-10 is an activator of TrkB/TrkC neurotrophin receptor and can induce TrkB, TrkC, ERK and AKT activation in vitro and in vivo.Formule :C27H33ClN2O4Degré de pureté :98.18%Couleur et forme :SolidMasse moléculaire :485.01